about
Atomic description of the immune complex involved in heparin-induced thrombocytopeniaAntigen and substrate withdrawal in the management of autoimmune thrombotic disorders.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.Lower limb gangrene postcardiac surgery.Novel diagnostic assays for heparin-induced thrombocytopeniaEmphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Heparin induced thrombocytopenia: review.Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.Platelet factor 4/heparin-particle gel immunoassay (PaGIA) is a weak method for heparin-induced thrombocytopenia (HIT) evaluation of post cardio-pulmonary bypass surgery patients.A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.Progressive thrombocytopenia after cardiac surgery in a 67-year-old man.DiagnoSTic assays for heparin-induced thrombocytopenia.Over-testing for heparin induced thrombocytopenia in hospitalized patients.Hospital-acquired thrombocytopenia.Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.Heparin Reexposure in Patients With a History of Heparin-Induced Thrombocytopenia.HIT or Miss: The Sequential Diagnostic Approach to Heparin-Induced Thrombocytopenia Illustrated in a Child With Acute Post-Streptococcal Glomerulonephritis.Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy.The platelet Fc receptor, FcγRIIa.A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).A high-value cost conscious approach to minimize heparin induced thrombocytopenia antibody (HITAb) testing using the 4T score.The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH.Pseudothrombocytopenia with multiple anticoagulant sample collection tubes.Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia.Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients.Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature.Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons.A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux.Immobilized heparin and its anti-coagulation effect on polysulfone membrane surface.False positive immunoassay for heparin-induced thrombocytopenia in the presence of monoclonal gammopathy: a case report.Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty.
P2860
Q30665349-05E39870-E946-491A-9FDF-6F689195ACF9Q33403225-A46BB3F5-B913-4000-8553-5A8B83BCFFFCQ33403395-3D471CCE-6B96-48BB-999F-C17C947F7532Q33405946-E65B7AC9-0909-47CC-8AEC-80797E73BE0FQ33406133-5F64A1F3-5319-4D71-AFDB-34FA7B5FF368Q33406904-7D6D3157-5F02-46B5-BC04-EF0A787CE28CQ33410083-2BC48922-6363-4E47-A008-61297BCC03EFQ33410765-DAC66965-2458-4027-9DA3-057ADF7D462BQ33413476-0DD25257-AE0E-4855-8F9D-0ABC7D6EE9D1Q33414139-5262388A-66B8-42E2-A773-FC215AE407E9Q33414796-92F921A3-8ED5-4F74-BF97-6D9A6F6046E9Q33415273-3B4C7258-B3BC-433F-A207-6709E24F0C2FQ33417093-C831E213-B9C1-4BBD-8409-9CB0A075AB71Q33419312-77ECDA4A-5CB9-4EB6-86CB-3D6067753D21Q33419774-B5534630-407E-4BA9-8674-64FE7CA8081DQ33421407-CB90D997-08EE-4504-84A0-5DF220D2C5C3Q33422750-AB525CB3-C313-4242-BA76-20ED6B8954EEQ33425127-3E8A0D8C-8B00-41A4-841F-69CBA0A3AD93Q33427010-7EF108A5-0CB3-4EEB-8034-083259F097F9Q33430223-8DF10D5D-97B3-4225-A9C1-056F37322ED4Q33430677-0CBC069B-0E5E-46F1-990E-B50D81CE0924Q33433623-4AE8C86D-DE6A-4B4B-B591-4E1165B75862Q33435819-710FF8A9-7EBD-4A52-984D-658D338CA974Q33436952-6F8FFAED-308B-491E-9F88-7EF02D6408B4Q33439192-AE4BDC95-A62B-455B-A96F-415F97B2F2ACQ33440222-095F06B3-6881-4B6E-ADFD-2EAD572CE2BCQ33440890-8E866CB4-B34C-42DE-8EFE-CDB78809D6C5Q33441202-1EAB6C38-2E4E-4F74-BB7D-A2BF5D16B7B5Q33442571-6025209E-561A-47AC-838D-68C1DA1969B1Q33443809-58D995B9-1C1A-4B2D-B754-D902A6ED9AF9Q40962346-3625CD55-4835-49CD-BCA7-C12A17DEB80EQ42423778-51DB3015-F906-4A2D-94E7-E532410AF6D7Q44839480-B56893C3-A6DA-48D1-8850-E1F5336440B9Q47133217-C8F9AE72-06CA-4F31-A954-8FD8CAC621EFQ53754886-ADDBD7A3-AD55-472A-B55F-B635A933DBAC
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
How I treat heparin-induced thrombocytopenia.
@ast
How I treat heparin-induced thrombocytopenia.
@en
type
label
How I treat heparin-induced thrombocytopenia.
@ast
How I treat heparin-induced thrombocytopenia.
@en
prefLabel
How I treat heparin-induced thrombocytopenia.
@ast
How I treat heparin-induced thrombocytopenia.
@en
P1433
P1476
How I treat heparin-induced thrombocytopenia.
@en
P2093
Adam Cuker
Douglas B Cines
P304
P356
10.1182/BLOOD-2011-11-376293
P407
P577
2012-01-13T00:00:00Z